Upcoming, not missing, posts...These are some of the topics and posts that I have in mind, with some being in advanced research stages. Except for (A), titles will be different than stated here.
(A) Bioasis, Chiesi and Protalix, Part 2 (this weekend)
(B) Fun with BBB math. (very soon)
(C) Bioasis and Alzheimer's Disease
(D) Bioasis Overview with elements of (H), below.
(E) Progranulin
(F) A Denali-related post with a focus to be revealed later.
(G) The need for more imaginative and informed investor relations.
(H) A new way to describe, brand and market Bioasis.
(I) Regular feature posts relating to industry news.
(J) Other posts that relate to the upcoming AGM and life after the AGM
(K) And posts that are contingent on the nature of my relationship with Bioasis.
(L) Getting deals done with the xB3 Platform - issues and opportunities
It's a heavy workload but like I said, it's time to get aggressive in the fight to defend Bioasis AND its shareholders, and with respect to how Bioasis is viewed, by both investors and by the company, itself.
If you have any topics or questions that you think could or should find their way into StoxComm posts, please let me know, privately. (I won't discuss them here.)
John Davenport
jd@stoxcomm.com
250-255-8442